Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues
L Peyrin-Biroulet, WJ Sandborn… - Therapeutic …, 2021 - journals.sagepub.com
In the 1990s, tumour necrosis factor-α inhibitor therapy ushered in the biologic therapy era
for inflammatory bowel disease, leading to marked improvements in treatment options and …
for inflammatory bowel disease, leading to marked improvements in treatment options and …
Tumor necrosis factor's pathway in Crohn's disease: potential for intervention
C Pagnini, F Cominelli - International journal of molecular sciences, 2021 - mdpi.com
Crohn's disease (CD) is a chronic disorder characterized by full thickness patchy
inflammation of the gastrointestinal tract. The pathogenesis is multifactorial and involves …
inflammation of the gastrointestinal tract. The pathogenesis is multifactorial and involves …